Bethyl Laboratories, Inc. | Fortis Life Sciences

Bethyl Laboratories, Inc. | Fortis Life Sciences is a leading provider of top-quality antibody products and services with a history dating back to 1972. The company is committed to manufacturing novel antibodies for both clinical and research applications with the intention of accelerating cell biology-based discoveries. Bethyl's dedication to quality assurance is evident in the production and affinity purification of all antibodies by antigen specific affinity chromatography at its singular facility in Montgomery, TX.

Through extensive collaborations and scholarly searches, Bethyl continues to discover new and emerging proteins of interest, actively producing antibodies to complement these discoveries. The company's dedication to quality is emphasized through the validation of its antibodies across a wide range of applications, including ELISA, western blot, immunoprecipitation, ChIP, Proximity Ligation Assay (PLA), immunohistochemistry, and immunocytochemistry.

The recent merger of Bethyl with Fortis Life Sciences enhances the company's position in the biopharma, biotechnology, healthcare, and manufacturing sectors. While the specific details of the most recent investment and the involved investors are not disclosed, Bethyl's continuous efforts to innovate and expand its portfolio make it an attractive prospect for potential investors seeking participation in the life sciences industry.